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ABSTRACT: Multisite phosphorylation is a common pathway to
regulate protein function, activity, and interaction pattern in vivo, but
routine biochemical analysis is often insuﬃcient to identify the
number and order of individual phosphorylation reactions and their
mechanistic impact on the protein behavior. Here, we integrate
complementary mass spectrometry (MS)-based approaches to
characterize a multisite phosphorylation-regulated protein system
comprising Polo-like kinase 1 (Plk1) and its coactivators Aurora
kinase A (Aur-A) and Bora, the interplay of which is essential for
mitotic entry after DNA damage-induced cell cycle arrest. Native MS
and cross-linking−MS revealed that Aur-A/Bora-mediated Plk1
activation is accompanied by the formation of Aur-A/Bora and
Plk1/Bora heterodimers. We found that the Aur-A/Bora interaction is
independent of the Bora phosphorylation state, whereas the Plk1/
Bora interaction is dependent on extensive Bora multisite phosphorylation. Bottom-up and top-down proteomics analyses
showed that Bora multisite phosphorylation proceeds via a well-ordered sequence of site-speciﬁc phosphorylation reactions,
whereby we could reveal the involvement of up to 16 phosphorylated Bora residues. Ion mobility spectrometry−MS
demonstrated that this multisite phosphorylation primes a substantial structural rearrangement of Bora, explaining the
interdependence between extensive Bora multisite phosphorylation and Plk1/Bora complex formation. These results represent a
ﬁrst benchmark of our multipronged MS strategy, highlighting its potential to elucidate the mechanistic and structural
implications of multisite protein phosphorylation.
■ INTRODUCTION
The post-translational phosphorylation of proteins at more
than one residue (multisite phosphorylation) is a long-known
concept of cellular protein regulation.1,2 Multisite phosphor-
ylation of key regulatory proteins, such as the microtubule-
associated protein tau and the tumor suppressor p53, has been
related to the pathogenesis of several neurodegenerative
diseases and human cancers.3,4 Moreover, there is increasing
evidence that multisite phosphorylation is a universal regulatory
mechanism for the correct timing of many cell cycle related
processes.5−7 As regulatory cell cycle kinase/substrate systems
are important drug targets,8,9 a thorough molecular under-
standing of multisite phosphorylation in the cell cycle is crucial
to reveal new druggable protein regions or highlight oﬀ-target
eﬀects of known inhibitors.10,11 However, apart from a few
fascinating exceptions,12−15 cell cycle kinase/substrate systems
have primarily been characterized with respect to their general
cytophysiological function, rather than their molecular
mechanism. This is mainly due to a lack of robust methods
to simultaneously monitor the number, site location, and
mechanistic implications of multisite protein phosphorylation.
Classical biochemical methods to investigate protein phosphor-
ylation, such as radiolabeling with [γ-32P]-ATP, detection by
phospho-site-speciﬁc antibodies, and phosphomimetic amino
acid substitutions, are either limited in their ability to
distinguish between single-site and multisite phosphorylation
or require preliminary knowledge about the expected
phosphorylation sites. An unbiased probing of protein
phosphorylation is, in principle, facilitated by mass spectrom-
etry (MS)-based high-throughput phosphoproteomics, but, as
phosphorylation patterns are typically identiﬁed at the peptide
level, information on the interdependence and sequence of
individual phosphorylation reactions is mostly lost. Moreover,
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none of the aforementioned methods provide a direct readout
for structural implications of the phosphorylation process, such
as conformational changes or protein complex formation, which
are often critical for the mechanistic understanding of multisite
phosphorylation.12,15−17
Thus, analytical tools are needed to characterize multisite
phosphorylation in molecular detail, speciﬁcally the reaction
kinetics at protein and protein complex level, the diﬀerential
reactivity of the phosphorylatable amino acids, and the
occurrence of phosphorylation-induced cooperative eﬀects on
protein structures or interaction patterns. We have previously
shown that a subset of these aspects, namely, phosphorylation
kinetics and protein interactions, can be simultaneously probed
by high-resolution MS analysis under nondenaturing conditions
(native MS)18 using an Orbitrap EMR mass analyzer.19,20 Most
importantly, high-resolution native MS enables the detection
and mass separation of all diﬀerentially phosphorylated protein
and protein complex species (phospho-isoforms), even if their
relative mass diﬀerences are as little as 0.05%.18 Next to native
MS, there are several complementary MS-based strategies, such
as cross-linking−MS, top-down proteomics, and ion mobility
spectrometry (IMS)−MS, that can be used to probe additional
aspects of multisite phosphorylation (Figure 1A). Cross-
linking−MS reveals (phosphorylation-dependent) protein
interactions and conformations in solution by covalent
chemical linkage and subsequent MS-based identiﬁcation of
the cross-linked residues.21,22 Top-down proteomics ap-
proaches facilitate the localization of phosphorylated residues
on individual phospho-isoforms by sequencing the intact
proteins in the gas phase.23 This provides information on the
sequential order of residue-speciﬁc phosphorylation reactions
and, if combined with peptide-centric bottom-up proteomics,
also the extent of phosphorylation on each residue.24−26
Furthermore, IMS−MS can monitor the inﬂuence of
phosphorylation on the conformational dynamics of proteins
and protein complexes,27,28 as it gives information on the shape
and size of proteins based on their drift time through a gas-
ﬁlled mobility cell.29 Together, these methods provide diﬀerent
information about the phosphorylation reaction but require the
same initial sample preparation steps, starting from an in vitro
kinase reaction under physiological conditions. Therefore, they
can be readily combined to elucidate multisite protein
phosphorylation processes in a reasonable time frame and
with minimal sample consumption (Figure 1A).
In our previous proof-of-concept studies on multisite
phosphorylation, we used either top-down proteomics24 or a
combination of native MS and bottom-up proteomics18 to
probe the binary Aur-A kinase domain/Bora and Plk1/Bora
systems. We hypothesized that integrating these strategies with
the above-mentioned complementary MS methods enables the
mechanistic investigation of systems with more complex
phosphorylation and interaction patterns. Therefore, we set
Figure 1. Analyzing multisite phosphorylation and protein complex formation by integrating mass spectrometric strategies. (A) Mechanistic aspects
of multisite phosphorylation that can be addressed by complementary MS techniques. Techniques that are best suited to monitor a certain aspect are
indicated by “+”. Techniques that allow the detection of some but not all features related to a certain aspect are denoted by “∼”. (B) Current
mechanistic knowledge of the Aur-A/Bora-catalyzed Plk1 activation. Plk1 is activated through phosphorylation of Thr210, which is jointly catalyzed
by Aur-A and Bora. Although Bora is known to contain binding and phosphorylation sites of Aur-A and Plk1, it is unclear whether and how protein
complex formation and Bora phosphorylation aﬀect Plk1 activation.
ACS Central Science Research Article
DOI: 10.1021/acscentsci.6b00053
ACS Cent. Sci. 2016, 2, 445−455
446
out to characterize the phosphorylation-induced activation of
Polo-like kinase 1 (Plk1) by full-length Aurora kinase A (Aur-
A) and its protein cofactor Bora, a complex and biologically
relevant three protein system in which the role of multisite
phosphorylation remains to be deciphered. Plk1 activation is
essential for cells to enter mitosis after recovery from a DNA
damage-induced cell cycle arrest, as shown by a wide range of in
vivo studies.30−33 While the cytophysiological implications of
Plk1 activation have been described in detail, its molecular
mechanism is still poorly understood. To date, it is only known
that Plk1 is activated through the Aur-A-catalyzed phosphor-
ylation of Thr210 and that this process is augmented by the
Aur-A activator Bora (Figure 1B).32,33 Bora is a largely
disordered protein that becomes multiply phosphorylated in
vivo by several kinases.34−36 Its N-terminal domain is a stable
interaction partner and a phosphorylation substrate of Aur-A,37
suggesting that Aur-A activation involves the Bora N-terminus.
Interestingly, the Bora N-terminus can also be bound and
phosphorylated by Plk1.31 Neither the speciﬁc sites nor the
functions of these N-terminal Bora phosphorylations have yet
been characterized. Additionally, Plk1 can phosphorylate Bora
at its C-terminal residues Ser497 and Ser501, resulting in Bora
degradation.31,38 This degradation process will not be studied
since it commences after the initial Aur-A/Bora-mediated Plk1
activation. Here, we aim to characterize the complex interplay
of Plk1, Aur-A, and the Bora N-terminus (residues 1−150, from
here on termed BoraNT) in mechanistic detail, speciﬁcally
focusing on the implications of the BoraNT phosphorylation
status, its phosphorylatable sites, and the sequential interactions
among the three proteins.
Using native MS and cross-linking−MS, we demonstrate that
Aur-A/BoraNT complex formation is independent of the BoraNT
phosphorylation state. In contrast, substantial Plk1/BoraNT
complex formation depends on the extensive Plk1- and Aur-
A-catalyzed multisite phosphorylation of BoraNT, with more
than 75% of its Ser and Thr residues being phosphorylated.
With top-down and quantitative bottom-up proteomics
approaches, this BoraNT multisite phosphorylation could be
fully characterized at the amino acid residue level. Pushing the
limits of top-down proteomics, we localize up to 16 BoraNT
phosphorylation sites and deﬁne the order by which Plk1 and
Aur-A process these substrate sites. By means of IMS−MS, we
observe that these phosphorylation events induce a signiﬁcant
conformational change of BoraNT, providing a rationale for the
correlation between BoraNT multisite phosphorylation and
enhanced Plk1/BoraNT complex formation. Together, the
complementary mass spectrometric data give detailed molec-
ular insights into the Aur-A/Bora/Plk1 reaction mechanism,
emphasizing the potential of our integrated MS approach to
Figure 2. Monitoring the Aur-A/BoraNT/Plk1 system with native MS. Shown are mass spectra of an equimolar mixture (5 μM) of Aur-A, BoraNT,
and Plk1 before (A) and after (B) 5 h incubation with Mg-ATP. Peaks are labeled with their respective charge state and colored according to the
protein species they represent. The detected protein and protein complex species, the expected molecular weight of their unphosphorylated isoform,
and the number of phosphorylations (P) on their most abundant phospho-isoform are indicated in the insets of A and B.
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comprehensively describe the mechanistic principles and
structural consequences of multisite phosphorylation.
■ RESULTS
Time-Resolved Native MS Analysis Elucidates the
Interplay between Multisite Phosphorylation and
Stable Interactions in the Tripartite Aur-A/BoraNT/Plk1
System. Our MS-based strategy is centered on high-resolution
native Orbitrap MS, as it provides an accurate readout for all
phosphorylation events at the protein and protein complex
level. Previously, this has enabled us to qualitatively prove
stable complex formation between the Aur-A kinase domain
and BoraNT, while simultaneously following the Aur-A-catalyzed
BoraNT phosphorylation.18 To probe the interplay of Aur-A,
BoraNT, and Plk1, we employ high-resolution native MS in such
a way that allows us to monitor not only protein
phosphorylation states but also the relative abundances of
emerging noncovalent protein complexes (see Supporting
Information). Representative native mass spectra obtained for
a mixture of Aur-A, BoraNT, and Plk1 before and after
incubation with Mg-ATP (see Figure S1 for sequences and
domain architecture of the three proteins) are shown in Figure
2. The native mass spectra show ion signals of all individual
proteins and the binary noncovalent Aur-A/BoraNT and Plk1/
BoraNT heterodimers. Before incubation with Mg-ATP, the
mass spectrum exhibits single peaks for the BoraNT and Plk1
charge states, illustrating that they are completely unphos-
phorylated (Figure 2A, insets). In contrast, the Aur-A charge
states are split into a ﬁne structure of peaks, representing
diﬀerent phospho-isoforms. This is due to the autophosphor-
ylation activity of Aur-A during recombinant production in
Escherichia coli.39 After incubation with Mg-ATP, diﬀerent
phospho-isoforms are detected for all present species,
demonstrating that multisite phosphorylation is a universal
characteristic of the Aur-A/BoraNT/Plk1 interplay (Figure 2B,
insets). These protein isoforms diﬀer by only 80 Da (the mass
of a phosphate group), yet they are fully baseline resolved in
the native Orbitrap mass spectra. This superior mass resolution,
which outperforms any gel- or chromatography-based protein
separation method, enables precise relative phospho-isoform
quantitation and the determination of intensity-weighted
average phosphorylation states to derive phosphorylation
progress curves.18
Comparing the native mass spectra before and after
incubation with Mg-ATP highlights three main characteristics
of the Aur-A/BoraNT/Plk1 interplay. First, Plk1 is multiply
phosphorylated by Aur-A, demonstrating the existence of
additional substrate sites next to the well-known activation site
Thr210. Second, the noncovalent Aur-A/BoraNT complex is
formed with and without addition of Mg-ATP, whereas the
noncovalent Plk1/BoraNT complex is only detected in the
presence of Mg-ATP, when all proteins have become
phosphorylated. Third, BoraNT, which contains 28 Ser and
Thr residues, displays extensive multisite phosphorylation, with
its most abundant phospho-isoforms carrying 16−17 phosphor-
ylations. As a consequence, also the Aur-A/BoraNT and Plk1/
BoraNT heterodimers display extensive multisite phosphoryla-
tion.
Since full-length Bora is known to enhance the catalytic
activity of Aur-A toward Plk1,30,32,33 we initially examined
whether BoraNT shows the same eﬀect during in vitro Plk1
activation. To this end, the Plk1 phosphorylation state was
analyzed after 1 h incubation with BoraNT and/or Aur-A
(Figure S2A). Unphosphorylated Plk1 remained the most
abundant species after incubation with either BoraNT or Aur-A
alone. Adding Aur-A and BoraNT in combination, however,
renders 2−3× phosphorylated Plk1. This conﬁrms that BoraNT,
just as full-length Bora, enhances the Aur-A-mediated Plk1
phosphorylation.
The positive eﬀect of BoraNT during Plk1 activation could be
due to Aur-A/BoraNT complex formation, since the Aur-A/
BoraNT heterodimer seems to be continuously present in the
Aur-A/BoraNT/Plk1 system (Figure 2). To probe this
hypothesis, we followed the Aur-A/BoraNT/Plk1 reaction
using native MS. The corresponding phosphorylation progress
curves are shown in Figure S2B. It becomes apparent that
already at the third time point, i.e., after 10 min, all species
contain more than one phosphorylation. At this point,
conventional (e.g., radiolabeling-based) in vitro kinase assays
would report phosphate incorporation in all species, complicat-
ing the further monitoring of the reaction. Since our high-
resolution native MS approach distinguishes all individual
phospho-isoforms (Figure 2), we are able to conﬁdently follow
the reaction beyond single-site phosphorylation and probe Aur-
A/BoraNT/Plk1 multisite phosphorylation, which takes more
than 5 h to complete. This rather long time frame indicates that
the numerous phosphorylatable sites within the Aur-A/BoraNT/
Plk1 system span a wide range of reactivities.
In parallel, we also monitored the Aur-A/BoraNT/Plk1
reaction with respect to the relative Aur-A/BoraNT complex
abundance in the presence and absence of Mg-ATP. Under
both conditions, the Aur-A/BoraNT complex abundance
remained constant (Figure 3A, upper graph), although adding
Mg-ATP caused progressive phosphorylation of both the Aur-
A/BoraNT complex and its constituent monomers (Figures S2B
and 3A, lower graph). Aur-A/BoraNT complex formation in the
presence of Plk1, therefore, does not depend on the BoraNT
phosphorylation state. When the Aur-A/BoraNT complex
formation was probed in the absence of Plk1, however, we
found that Aur-A binds less eﬃciently to unphosphorylated
BoraNT than to BoraNT that had been prephosphorylated prior
to the binding experiment (Figure 3B). This phosphorylation
dependence of the Aur-A/BoraNT interaction appears to be
somehow mitigated by Plk1. Interestingly, the Aur-A/BoraNT
complex abundance remains the same when Plk1 is replaced by
the Plk1-K82R mutant (Figure S2C), which is catalytically
inactive and does not stably associate with BoraNT (see Figure
S3). Thus, Aur-A/BoraNT heterodimerization seems to be
inﬂuenced by the mere presence of Plk1, rather than its kinase
activity or its stable binding to BoraNT. Possibly, this eﬀect
could be caused by short-lived interactions between Plk1 and
the Aur-A/BoraNT complex. In summary, we observe that the
Aur-A/BoraNT complex forms stably throughout the Aur-A/
BoraNT/Plk1 reaction and that this process is directly aﬀected
by the presence of Plk1. This suggests a direct involvement of
the Aur-A/BoraNT heterodimer in the Plk1 activation process.
In contrast to the continuously present Aur-A/BoraNT
heterodimer, the Plk1/BoraNT complex only became signiﬁ-
cantly abundant after Aur-A, BoraNT, Plk1, and Mg-ATP had
reacted for 40−60 min (Figure 4A). At diﬀerent reaction times,
we determined the phosphorylation state of the Plk1/BoraNT
complex in comparison with the sum of phosphorylations
found on the concomitantly detected Plk1 and BoraNT
monomers (Figure 4A, solid vs dashed gray line). These
phosphorylation curves overlapped during the ﬁrst 20 min of
the reaction when Plk1/BoraNT complex abundance was still
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marginal. This indicates that, at this stage, Plk1 and BoraNT
associate irrespective of their phosphorylation states. However,
the phosphorylation curves started to deviate as soon as the
rapid increase in Plk1/BoraNT complex abundance was
observed (Figure 4A). At this point of the reaction, the Plk1/
BoraNT complex exhibited substantially higher phosphorylation
states than its constituent monomers. As such, Plk1/BoraNT
complex formation may be promoted by the extensive multisite
phosphorylation of its constituents, from here on termed
“hyperphosphorylation”. In the mass spectra, this hyper-
phosphorylation coincided with a bimodal mass distribution
of the Plk1/BoraNT complex phospho-isoforms (Figure 4B, left
panel). Interestingly, a bimodal phospho-isoform distribution
was also observed for the BoraNT monomer, transitioning to
hyperphosphorylated BoraNT when >10 phosphorylations are
present, but not for the Plk1 monomer (Figure 4B). Therefore,
the bimodal phospho-isoform distribution and apparent
hyperphosphorylation of the Plk1/BoraNT complex is likely
caused by the binding of Plk1 to hyperphosphorylated BoraNT.
Notably, the bimodal phospho-isoform distribution was initially
most clearly seen in the Plk1/BoraNT complex, whereas higher
BoraNT phosphorylation states were severely depleted (Figure
4B, left panel). A clear bimodal phospho-isoform distribution
for unbound BoraNT was only detected after the Plk1/BoraNT
complex had become fully hyperphosphorylated (Figure 4B,
right panel). These results suggest that Plk1 interacts
preferentially with hyperphosphorylated BoraNT, resulting in
more eﬃcient Plk1/BoraNT complex formation (see also Figure
5A for the results of complementary SDS−PAGE-based assays,
which will be discussed later on).
As both BoraNT hyperphosphorylation and Plk1/BoraNT
heterodimerization were observed in native MS, we set out to
investigate whether these phenomena are interdependent. Plk1
and BoraNT contain distinctive kinase-speciﬁc substrate sites
that become readily modiﬁed.24,32,33 Therefore, we ﬁrst
speculated that preliminary phosphorylation of these sites on
Plk1 or BoraNT might be suﬃcient to facilitate Plk1/BoraNT
Figure 3. Aur-A/BoraNT complex formation and phosphorylation. (A)
Abundance (upper plot) and phosphorylation state (lower plot) of the
Aur-A/BoraNT complex in the presence of Plk1. Shown are three time
points of the reaction monitored in the presence of Mg-ATP.
Additionally, two control reactions without Mg-ATP were allowed to
proceed for 180 and 300 min, respectively. (B) Complex formation
between Aur-A and unphosphorylated or prephosphorylated BoraNT in
the absence of Plk1 (no Mg-ATP added during the binding
experiment). BoraNT was prephosphorylated by overnight incubation
with catalytic amounts of Aur-A, yielding 3−4× phosphorylated
BoraNT isoforms. The corresponding phosphorylation sites have been
described previously.18 The relative complex abundances were
calculated as the intensity ratio of BoraNT-bound Aur-A to total Aur-
A, considering all present phospho-isoforms. Error bars represent
standard deviations from duplicates.
Figure 4. Plk1/BoraNT complex formation and phosphorylation. (A)
Evolution of phosphorylation state and abundance of the Plk1/BoraNT
complex over time, as derived from the native MS experiments in the
presence of Aur-A and Mg-ATP. The number of phosphorylations was
calculated as a weighted average based on the phospho-isoform
intensities in the native mass spectra. The relative complex abundance
was calculated as the intensity ratio of BoraNT-bound Plk1 to total
Plk1, considering all present phospho-isoforms. Error bars represent
standard deviations from duplicates. (B) Zero charge state mass
spectra of BoraNT, Plk1, and the Plk1/BoraNT complex after 60 and 90
min of incubation, demonstrating the earlier appearance of the
bimodal phospho-isoform distribution in the Plk1/BoraNT complex as
compared to BoraNT. The highest phosphorylation state detected for
each species (P) is indicated.
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complex formation without BoraNT hyperphosphorylation. To
test this hypothesis, we prephosphorylated Plk1 or BoraNT (see
Figure S3A), subsequently added the respective interaction
partner at a 1:1 molar ratio, and monitored Plk1/BoraNT
complex formation for 1 h. Under all tested prephosphorylation
conditions, less Plk1/BoraNT complex was formed compared
with our initial experiment, where we incubated stoichiometric
amounts of Aur-A, BoraNT, and Plk1 without pretreatment
(Figure S3A). Thus, prephosphorylation of the most reactive
substrate sites within BoraNT and Plk1 is not suﬃcient for
eﬃcient Plk1/BoraNT heterodimerization, evidencing that a
stable Plk1/BoraNT interaction requires higher phosphorylation
states, likely achieved by the subsequent phosphorylation of less
reactive sites.
Next, we asked whether the Plk1/BoraNT interaction
necessitates the kinase activity of both Plk1 and Aur-A.
Replacing wild-type Plk1 by the kinase-inactive mutant Plk1-
K82R prevented both BoraNT hyperphosphorylation and stable
Plk1/BoraNT complex formation during 5 h of incubation
(Figure S3B). The same eﬀect occurred when only wild-type
Plk1 but no Aur-A was present in the reaction mix. Adding Aur-
A after 5 h, however, led to an immediate increase in
phosphorylation levels and to formation of the Plk1/BoraNT
complex, which was again accompanied by preferred association
of Plk1 with hyperphosphorylated BoraNT (Figure S3C).
In summary, our native MS results demonstrate that Plk1/
BoraNT heterodimerization depends on the activity of both Aur-
A and Plk1 and is closely related to BoraNT hyperphosphor-
ylation. By contrast, Aur-A/BoraNT heterodimerization is
independent of kinase activities and observed throughout the
Aur-A/BoraNT/Plk1 reaction.
Cross-Linking−MS Conﬁrms the Aur-A/BoraNT/Plk1
Interaction Pattern and Reveals the Intramolecular
Organization of Plk1. Complementary to the native MS
experiments, we followed the Aur-A/BoraNT/Plk1 reaction in
the presence of Mg-ATP with cross-linking−MS to obtain
information on inter- and intramolecular protein interactions.
These interactions were captured by amine-reactive chemical
cross-linking using the popular bis(sulfosuccinimidyl)suberate
(BS3) cross-linker. The cross-linked species were subsequently
dephosphorylated to prevent phosphorylation-dependent elec-
trophoretic mobility shifts and separated by SDS−PAGE
(Figure 5A, upper gel). In line with the native MS data, gel
bands with molecular weights corresponding to the binary Aur-
A/BoraNT and Plk1/BoraNT complexes were readily detected
(Figure 5A, blue and orange arrows). Additionally, we observed
a band that corresponds to a mixture of diﬀerent species
(Figure 5A gray arrow), possibly including transiently formed
protein assemblies (Figure S4). This supports our hypothesis
that some species, notably the Aur-A/BoraNT complex and Plk1
(see Figure 3), may aﬀect each other through short-lived
interactions.
As the Aur-A/BoraNT complex is more abundant when
BoraNT is phosphorylated in the absence of Plk1 (Figure 3B),
we used these conditions to probe the Aur-A/BoraNT binding
interface. We identiﬁed 16 intermolecular Aur-A/BoraNT cross-
links (Figure S5, Table S1). While 12 of these cross-links
involve the highly mobile, and thus structurally less informative,
protein N-termini, we also identiﬁed four lysine−lysine cross-
links connecting less ﬂexible protein regions, which render
more stringent distance information. These cross-links point to
an interaction between BoraNT and C-terminal regions of Aur-A
(Figure S5), conﬁrming the previous observation that BoraNT
forms a stable complex with the C-terminal Aur-A kinase
domain.18
While the continuously formed Aur-A/BoraNT complex
represents a typical target for cross-linking−MS, this technique
can also be used to study nonpermanently formed
interactions,21 such as the Plk1/BoraNT complex. Strikingly,
the time-dependent Plk1/BoraNT complex formation can be
precisely monitored with chemical cross-linking, as evidenced
by the emergence of an 88 kDa band on SDS−PAGE after 40
min reaction time (Figure 5A, orange asterisk in upper gel).
The identity of the Plk1/BoraNT complex was proven by
bottom-up proteomics analysis of the respective gel band,
revealing six intermolecular Plk1/BoraNT cross-links (Figure
S6A, Table S1).
In parallel to the cross-linking experiment, we left half of the
reaction mix untreated (no cross-linking and dephosphoryla-
Figure 5. Aur-A/BoraNT/Plk1 interactions studied by chemical cross-
linking. (A) The Aur-A/BoraNT/Plk1 reaction time course monitored
by SDS−PAGE. Samples were either chemically cross-linked and
subsequently dephosphorylated (upper gel) or left untreated (lower
gel). The occurrence of the Plk1/BoraNT complex and BoraNT
hyperphosphorylation are respectively indicated by orange and red
asterisks. The detected species are designated by arrows. The gray
arrow denotes a group of bands at 120−160 kDa, which represent,
according to MS analysis, a mixture of diﬀerent species including
complexes of dimeric Plk1 (∼139 kDa), Plk1/Aur-A 1:1 (∼116 kDa),
Plk1/BoraNT 2:1 (∼157 kDa), and possibly Aur-A/BoraNT/Plk1 1:1:1
(∼134 kDa), all of which likely arise from low-aﬃnity or less stable
interactions (see also Figure S4). (B) Cross-links connecting the N-
and C-terminal Plk1 regions mapped onto a Plk1 homology model
(Figure S7A). The cross-links were identiﬁed after incubating Aur-A,
BoraNT, and Plk1 for 5 h with and without Mg-ATP.
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tion), allowing us to analyze the progressive phosphorylation of
the three single proteins simultaneously to their interaction
pattern (Figure 5A, lower gel). Remarkably, the phosphorylated
BoraNT monomer splits into two diﬀerently migrating gel bands
(Figure 5A, red asterisk in lower gel) around the time when
Plk1/BoraNT complex formation was ﬁrst observed (Figure 5A,
orange asterisk in upper gel). This eﬀect is likely related to the
BoraNT phosphorylation state, since phosphorylation frequently
causes considerable mobility shifts on SDS−PAGE.40 The
detection of two clearly separated bands implies the coexistence
of diﬀerentially phosphorylated BoraNT isoforms at the same
time point. Bimodal phospho-isoform distributions were also
seen by native MS, ﬁrst for the Plk1/BoraNT complex and later
for unbound BoraNT (Figure 4B). These results support the
notion that the bimodality is observed as a result of BoraNT
hyperphosphorylation, resulting in enhanced Plk1/BoraNT
complex formation.
MS analysis of the Plk1/BoraNT heterodimer gel band
(Figure 5A, orange asterisk in upper gel) also revealed nine
intramolecular cross-links within Plk1. These cross-links shed
light on the conformation of Plk1 during its activation,
providing structural information that is complementary to the
protein interaction data shown above. Several intramolecular
cross-links connect N- and C-terminal Plk1 regions, suggesting
a globular conformation for phosphorylated, BoraNT-bound
Plk1 (Figure S6A). This is particularly interesting since
previous investigations of the Plk1 conformation led to
controversial results. On the one hand, it was proposed that
phosphorylation-induced activation and Bora binding trigger a
conformational opening of Plk1, separating its N- and C-
terminal domains.33,41 On the other hand, a recent study
suggested that the N- and C-terminal domains remain
associated upon Plk1 phosphorylation/activation.42 To further
inquire into this controversy, we probed the structures of
phosphorylated BoraNT-bound Plk1, phosphorylated mono-
meric Plk1, and unphosphorylated monomeric Plk1 in a
separate cross-linking−MS experiment. In all these cases, cross-
links between the N- and C-terminal Plk1 regions were always
observed (Figure S6B). We mapped these cross-links on a Plk1
homology model adopting an opened conformation (Figure
S7A). In this model, all cross-links between the Plk1 N- and C-
terminus fall beyond the maximum Cα−Cα distance of 38 Å
that can be bridged by the BS3 cross-linker (Figure 5B).43 In
contrast, all cross-links within the structurally well-characterized
Plk1 kinase domain exhibit Cα−Cα distances below 25 Å,
demonstrating the structural validity of our cross-linking−MS
approach (Figure S7B). Consequently, the cross-linking−MS
data strongly suggest that Plk1 does not undergo a conforma-
tional opening but retains a closed conformation throughout
the Aur-A/BoraNT/Plk1 reaction.
Bottom-Up and Top-Down Proteomics Reveal the
Sequence of Phosphorylation Reactions Leading to Plk1
Activation and BoraNT Hyperphosphorylation. According
to our analysis of the Aur-A/BoraNT/Plk1 reaction at protein
and protein complex level, two phosphorylated species are of
particular interest. On the one hand, Plk1 becomes multiply
phosphorylated by Aur-A, raising the question whether the
known substrate site Plk1-Thr21030,32,33 is the primary Aur-A
target in our assays. On the other hand, we have established
that BoraNT hyperphosphorylation is critical for Plk1/BoraNT
complex formation, encouraging a detailed investigation of the
site-speciﬁc phosphorylation reactions accompanying BoraNT
hyperphosphorylation.
First, we applied bottom-up proteomics to locate Plk1
residues that become phosphorylated in the presence of Aur-A
and BoraNT. To this end, we proteolyzed Plk1 with trypsin and
determined the extent of residue-speciﬁc phosphorylation at
peptide level using relative quantitation (see Supporting
Information). Quantitative bottom-up analysis revealed that
Thr210 on Plk1 is the most reactive Aur-A phosphorylation site
and becomes fully modiﬁed within 10 min (Figure 6A). The
secondary and tertiary phosphorylation sites are clearly less
reactive (16% and 3% phosphorylation occupancy after 10
min). This shows that Aur-A phosphorylates its primary in vivo
substrate Plk1-Thr210 with high speciﬁcity, substantiating the
functional validity of our in vitro assays.
Second, quantitative bottom-up proteomics was applied to
analyze the gel bands corresponding to diﬀerentially
phosphorylated BoraNT (Figure 5A, lower gel). The clear
separation of intermediately phosphorylated and hyperphos-
phorylated BoraNT on SDS−PAGE allowed us to locate three
residuesSer7, Thr48, and Ser86that were substantially
more phosphorylated in hyperphosphorylated BoraNT (Table
S2). This is most apparent for Thr48, which is entirely
unphosphorylated in intermediately phosphorylated BoraNT but
shows 83% phosphorylation occupancy upon BoraNT hyper-
phosphorylation. An exhaustive description of the BoraNT
Figure 6. Mapping of phosphorylation sites by peptide-centric
bottom-up (A) and protein-centric top-down (B) proteomics
approaches. All residues are numbered according to Figure S1. (A)
Plk1 phosphorylation sites mapped by bottom-up proteomics analysis
of Plk1 peptides after tryptic digestion. The site-speciﬁc phosphate
occupancy was determined by relative quantitation. Error bars
represent standard deviations from duplicates. (B) BoraNT phosphor-
ylation sites mapped by top-down analysis of 7−16× phosphorylated
intact BoraNT (see also Table S3). BoraNT is shown as a sequence bar
with all Ser and Thr residues being represented as vertical lines.
Depending on the BoraNT phospho-isoform in which these residues
were ﬁrst found to be phosphorylated, they are grouped in three
categories: detected before hyperphosphorylation (i.e., in the 7−10×
phosphorylated isoforms), detected during hyperphosphorylation (i.e.,
in the 11−13× phosphorylated isoforms), and detected after
hyperphosphorylation (i.e., in the 14−16× phosphorylated isoforms).
Ser7 and Ser86 are labeled with an asterisk because they become
partially modiﬁed before BoraNT hyperphosphorylation but their
phosphate occupancy substantially increases during the hyper-
phosphorylation process, as shown by quantitative bottom-up analysis
(Table S2).
ACS Central Science Research Article
DOI: 10.1021/acscentsci.6b00053
ACS Cent. Sci. 2016, 2, 445−455
451
hyperphosphorylation process using bottom-up proteomics was
prevented by incomplete sequence coverage and by the fact
that BoraNT analysis at the peptide level generally precludes the
assignment of phosphorylation sites to speciﬁc BoraNT
phosphorylation states. Such an assignment, however, can be
obtained by top-down proteomics, where intact proteins are
analyzed by MS, enabling the speciﬁc sequencing of individual
phospho-isoforms.24 This readily reveals the phosphorylation
sites corresponding to each BoraNT phospho-isoform, providing
information on the sequence of phosphorylation events and
potential crosstalk between phosphorylation sites. Moreover,
BoraNT species with the same number of phosphorylations but
diﬀerent phosphorylation sites, so-called positional isomers, can
be deciphered, as we have previously shown.24 The presence of
these positional isomers, however, also presents a particular
challenge for top-down proteomics.44 In general, top-down
analyses are highly demanding because the gas-phase
fragmentation of intact proteins produces numerous large and
highly charged fragment ions, complicating the interpretation of
the mass spectra.23,24 So far, top-down proteomics has been
successfully applied to proteins with up to ﬁve post-transla-
tionally modiﬁed residues.45 To overcome these boundaries, we
performed individual top-down analyses of the 7−16×
phosphorylated BoraNT isoforms and used an in-house
developed workﬂow (Brunner et al., manuscript in preparation,
see Supporting Information for a brief description) to establish
their respective modiﬁed sites (Table S3, Figure S8).
Reassuringly, 7× phosphorylated BoraNT contained all
phosphorylation sites that are most reactive according to our
bottom-up proteomics data and our previous top-down
proteomics analysis of singly and doubly phosphorylated
BoraNT.24 Noteworthy, the number of phosphorylations on
intact BoraNT (detected in the precursor ion mass spectrum
before fragmentation) was usually lower than the number of
(partially) phosphorylated residues (detected in the fragment
ion mass spectra after fragmentation). This shows that most of
the phospho-isoforms indeed comprise several positional
isomers with diﬀerent combinations of phosphorylation sites.
Consequently, some of the sequential steps toward the next
highest phospho-isoform merely presented a “ﬁlling up” of
partially modiﬁed sites. Still, from our data it became apparent
that BoraNT hyperphosphorylation follows a deﬁned succession
of site-speciﬁc modiﬁcations, since the vast majority of
phosphorylations had a unique starting point and we never
found more than two novel phosphorylations occurring in the
same phospho-isoform (Table S3).
A summary of all phosphorylation events detected with top-
down proteomics at diﬀerent stages of BoraNT hyperphosphor-
ylation is provided in Figure 6B. Consistent with the bottom-up
proteomics results, Thr48 becomes phosphorylated during the
transition to hyperphosphorylated BoraNT, which proceeds
when >10 phosphorylations are added (see Figure 4B).
Additionally, this transition is accompanied by the modiﬁcation
of Ser127 (Figure 6B). Together with the increased
phosphorylation of Ser7 and Ser86 upon BoraNT hyper-
phosphorylation, shown by quantitative bottom-up proteomics
(Table S2), we thus localized four phosphorylation reactions
that are indicative for the transition to hyperphosphorylated
BoraNT.
IMS−MS Reveals a Phosphorylation-Induced Con-
formational Change of BoraNT. The observation of bimodal
BoraNT phospho-isoform distributions with native MS and
SDS−PAGE (Figures 4B and 5A) indicates a rapid increase in
phosphorylation levels, which is likely attributable to four site-
speciﬁc phosphorylation events, as extracted from the top-down
and bottom-up proteomics data. Based on this ﬁnding, we
hypothesized that the rapidly elevated BoraNT phosphorylation
state is related to a conformational change of BoraNT that
exposes previously protected Ser/Thr residues, allowing them
to become phosphorylated by Aur-A/Plk1. To test this
hypothesis, we probed the phosphorylation-dependence of
the BoraNT conformation by performing IMS−MS experiments
on the equimolar Aur-A/BoraNT/Plk1 reaction mix. As the
mass spectra of the 8× charged BoraNT monomer illustrate, we
were able to distinguish the diﬀerent BoraNT phosphorylation
states (Figure 7, top panel), although the mass resolving power
of the used IMS−MS instrument (Synapt G1) is substantially
lower than that of the native MS instrument (Orbitrap EMR).
Moreover, we could reproduce the bimodal distribution of
BoraNT phosphorylation states, previously observed with native
Orbitrap MS.
Strikingly, this bimodal phospho-isoform distribution con-
curred with a distinct bimodal distribution of drift times (Figure
7). Higher phosphorylated forms exhibited shorter drift times,
implying a distinct and sudden structural compaction during
hyperphosphorylation (Figure 7, middle plots). After passing
the bimodal state, the BoraNT phospho-isoforms traveled almost
uniformly with the shorter drift time (Figure 7, right plots),
suggesting that later phosphorylation events do not have an
added eﬀect on the BoraNT conformation.
Similar results were obtained after hyperphosphorylating
BoraNT with catalytic amounts of Aur-A and Plk1, underpinning
that the observed conformational change of BoraNT only
depends on its extensive phosphorylation and not on stable
complex formation with Plk1 or Aur-A (Figure S9).
Consequently, both BoraNT hyperphosphorylation and its
related conformational change appear to be critical prereq-
uisites for the Plk1/BoraNT heterodimerization.
■ DISCUSSION
Beneﬁts of an Integrated MS-Based Approach for the
Investigation of Multisite Phosphorylation. Here, we used
a multifaceted mass spectrometric approach to investigate the
multisite phosphorylation-regulated tripartite system Aur-A/
BoraNT/Plk1. First, native MS was used to decipher the protein
Figure 7. Structural analysis of BoraNT by IMS−MS. Mass spectra (top
panel) and m/z vs drift time plots (middle panel) of the 8+ charge
state of BoraNT before (left), during (middle), and after (right)
hyperphosphorylation. The bottom panel includes the drift time
distributions of 8× and 17× phosphorylated BoraNT, which were
extracted from the spectra displayed above (indicated by shaded
funnels).
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interactions that occur during multisite phosphorylation, as it
can preserve such noncovalent interactions in the gas phase.
Thus, high-resolution native MS is ideally suited for the
simultaneous probing of protein complex abundances and
phosphorylation states (Figures 3 and 4). Complementary,
cross-linking−MS was applied to monitor the protein
interaction patterns, capturing these interactions covalently in
solution. Cross-linking−MS, as we have shown, provides
information on stable and transient protein complexes, binding
interfaces, and protein conformations (Figures 5 and S4−S6).
Next, advanced top-down proteomics experiments were
conducted to unambiguously localize multiple phosphorylation
sites and reveal the sequential order of these phosphorylation
reactions, while bottom-up proteomics analyses were per-
formed to add quantitative information on the extent of site-
speciﬁc phosphate incorporation (Figure 6). Finally, IMS−MS
was employed to monitor protein conformations in the context
of their phosphorylation and binding state (Figure 7). Our
results demonstrate that integrated MS approaches combine
the strength of each individual, yet diverse, MS technique. This
enables, for the ﬁrst time, the concurrent probing of overall
phosphorylation kinetics, residue-speciﬁc reactivities, protein
interaction dynamics, and structural transitions. As a result, we
obtained unique insights into the mutual dependence of these
aspects throughout the intricate Aur-A/BoraNT/Plk1 interplay.
Mechanistic Insights into the Phosphorylation and
Interaction Dynamics of Aur-A, BoraNT, and Plk1. It has
been established that the phosphorylation-induced activation of
Plk1 by Aur-A functionally depends on the presence of
Bora,30,32,33 probably involving the Bora N-terminus.31,37
However, the molecular mechanism of this process, especially
the role of multisite phosphorylation and reversible association,
was yet not well understood. Our analysis revealed that this
process is characterized by two critical steps, illustrating the
interdependence between multisite phosphorylation and
protein interaction dynamics in diﬀerent varieties (Figure 8).
Initially, Aur-A and BoraNT jointly catalyze the phosphor-
ylation-induced Plk1 activation, as shown by native MS and
bottom-up proteomics (Figures S2A and 6A). This mutual
activity and the continuous native MS-based detection of a
stable Aur-A/BoraNT heterodimer, which is directly inﬂuenced
by Plk1 (Figure 3), collectively suggest that the Aur-A/BoraNT
complex serves as the actual Plk1 activating entity, in agreement
with what has been hypothesized in a recent in vivo study.30
Conceivably, Plk1 activation could be triggered by an allosteric
eﬀect of BoraNT, making Aur-A’s active site more accessible for
Plk1-Thr210. Previous hypotheses that the activation process is
accompanied by a major conformational opening of Plk133,41
are contested by our cross-linking−MS data, which suggest a
constantly closed Plk1 conformation (Figures 5B and S6). In
agreement with a recent study,42 Plk1 activation is more likely
to be facilitated by relatively subtle conformational changes,
which are not easily detectable with chemical cross-linking.
Subsequently, the three constituent proteins engage in
mutual phosphorylations, proceeding toward BoraNT hyper-
phosphorylation. This, in turn, enables stable Plk1/BoraNT
complex formation, which is evidenced by native MS and
chemical cross-linking (Figures 4 and 5A). That BoraNT
hyperphosphorylation coincides with substantial Plk1/BoraNT
complex formation is likely related to a hyperphosphorylation-
induced conformational switch of BoraNT as indicated by its
bimodal phospho-isoform distribution (Figure 4B) and its
phosphorylation-induced structural compaction seen with
IMS−MS (Figure 7). Moreover, IMS−MS suggests the
coexistence of extended and compact BoraNT conformers
over several phosphorylation states. The progression between
these phosphorylation states, as we have demonstrated with
bottom-up and top-down proteomics, is characterized by
sequential site-speciﬁc phosphorylation reactions. Speciﬁcally,
we observe the (increased) phosphorylation of Ser7, Thr48,
Ser86, and Ser127 (Figure 6B), which probably become
exposed during the structural rearrangement of BoraNT.
Collectively, this supports the premise that the conformational
switch of BoraNT, and hence Plk1/BoraNT complex formation, is
induced by the sum of several Aur-A and Plk1-catalyzed
phosphorylations, rather than by the modiﬁcation of a single
site. We can thus show that Plk1/BoraNT complex formation is
a consequence of Plk1 activation and not its prerequisite, as
proposed earlier.33,41
Figure 8. Interaction and phosphorylation dynamics within the tripartite Aur-A/BoraNT/Plk1 system. The Aur-A/BoraNT/Plk1 interplay is
characterized by the initial eﬃcient Aur-A/BoraNT-catalyzed Plk1 activation, followed by the mutual enzymatic phosphorylation of all components,
which eventually leads to hyperphosphorylation and conformational compaction of BoraNT (indicated by red shading). This last step shifts the Plk1/
BoraNT binding equilibrium toward the Plk1/BoraNT complex, allowing substantial complex formation. In contrast, the Aur-A/BoraNT complex is
continuously present, raising the possibility that this complex acts as the Plk1 activator.
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In summary, the ﬁrst step of the Aur-A/BoraNT/Plk1 reaction
is characterized by a stable protein interaction (Aur-A/BoraNT)
that appears to directly aﬀect the protein phosphorylation
dynamics (of Plk1). Conversely, the second reaction step is
deﬁned by a succession of phosphorylation reactions (BoraNT
hyperphosphorylation) that immediately inﬂuences protein
conformations (BoraNT) and stable interactions (Plk1/BoraNT
complex formation). The molecular mechanism of the Aur-A/
BoraNT/Plk1 reaction is, thus, best described as an interplay of
dynamically changing phosphorylation and interaction net-
works (Figure 8).
These results eﬀectively complement the existing in vivo data
and highlight promising targets for future research. Such
investigations should focus on the comprehensive elucidation of
in vivo Bora phosphorylation states and their physiological role,
whereby the here presented data provide guidelines on which
sites to target. More generally, this work benchmarks what may
be achieved by MS-based structural biology, in studying not
only kinase−substrate relationships but any protein−protein
and protein−nucleic acid system that interacts via reversible
association and transfer of post-translational modiﬁcations.
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(32) Macůrek, L.; Lindqvist, A.; Lim, D.; Lampson, M. A.;
Klompmaker, R.; Freire, R.; Clouin, C.; Taylor, S. S.; Yaffe, M. B.;
Medema, R. H. Polo-like kinase-1 is activated by aurora A to promote
checkpoint recovery. Nature 2008, 455, 119−123.
(33) Seki, A.; Coppinger, J. A.; Jang, C.-Y.; Yates, J. R.; Fang, G. Bora
and the Kinase Aurora A Cooperatively Activate the Kinase Plk1 and
Control Mitotic Entry. Science 2008, 320, 1655−1658.
(34) Feine, O.; Hukasova, E.; Bruinsma, W.; Freire, R.; Fainsod, A.;
Gannon, J.; Mahbubani, H. M.; Lindqvist, A.; Brandeis, M.
Phosphorylation-mediated stabilization of Bora in mitosis coordinates
Plx1/Plk1 and Cdk1 oscillations. Cell Cycle 2014, 13, 1727−1736.
(35) Lee, Y.-C.; Liao, P.-C.; Liou, Y.-C.; Hsiao, M.; Huang, C.-Y.; Lu,
P.-J. Glycogen synthase kinase 3 β activity is required for hBora/
Aurora A-mediated mitotic entry. Cell Cycle 2013, 12, 953−960.
(36) Tavernier, N.; Noatynska, A.; Panbianco, C.; Martino, L.; van
Hove, L.; Schwager, F.; Leǵer, T.; Gotta, M.; Pintard, L. Cdk1
phosphorylates SPAT-1/Bora to trigger PLK-1 activation and drive
mitotic entry in C. elegans embryos. J. Cell Biol. 2015, 208, 661−669.
(37) Hutterer, A.; Berdnik, D.; Wirtz-Peitz, F.; Žigman, M.;
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